[eGongsi Notice] KOSPI - 19th

▲SK Innovation=Announced that its subsidiary SK On Hungary Kft. will issue new shares worth KRW 1,191.33 billion for facility funds. The method of capital increase is a rights offering to shareholders.

▲SK Innovation=Announced that it will hold an online investor relations (IR) meeting at 10 a.m. on the 29th. The main topics will be the 2nd quarter 2022 business performance and market outlook by business segment.

▲HDC Labs=Announced that it signed a contract worth KRW 22.017753055 billion with Hanwha Construction for the ‘A/V, BGM, and public address system construction’ of the Yeongjongdo Inspire Complex Resort Development Project. This amount corresponds to 8.0% of recent sales.

▲Korea Line=Announced that it decided to lend KRW 42.0615 billion to its subsidiary Korea Line LNG Co., Ltd. This is 2.77% of equity capital, with the transaction date set for the 20th. The interest rate is 4.90%, and the loan purpose is for facility and operating funds.

▲Chong Kun Dang=Announced that its gastritis treatment drug ‘Jitec’ received product approval from the Ministry of Food and Drug Safety. The product name is Jitec Tablets 75 mg (Cinnamomi Cortex Dry Extract), and the target diseases are improvement of gastric mucosal lesions in acute and chronic gastritis. The application date was February 9, and the approval date was the 18th. Chong Kun Dang stated it plans to launch the product after completing health insurance listing procedures.

▲HDC Hyundai Development Company=Announced that at the shareholders’ meeting on the 19th, the proposals to appoint directors Choi Ik-hoon and Kim Hoe-eon were approved as originally proposed.

▲HDC Hyundai Development Company=Announced that it will lend KRW 40 billion to its affiliate HDC I&C Co., Ltd. The interest rate is 3.81%, and the loan purpose is for repayment of borrowings and other lending purposes.

▲Lock&Lock=Decided to cancel 1,349,970 common shares. The par value per share is KRW 500, and the total cancellation amount is KRW 14.8576349 billion. The cancellation is scheduled for the 26th.

▲Hancom Lifecare=Announced that it signed a supply contract with the Defense Acquisition Program Administration for 14 items including 2022 Reserve Forces combat training equipment components. The contract amount is KRW 1.6203 billion, which corresponds to 1.22% of recent sales.

This content was produced with the assistance of AI translation services.